Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters
908 Devices Inc. (MASS)
Company Research
Source: Business Wire
BOSTON--(BUSINESS WIRE)--Today, 908 Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ MAVEN for automated control of glucose and lactate levels in cell cultures. The combined solution will help scientists measure critical process parameters in bioreactors, offering continuous, real-time analysis without the need for manual sampling.In the field of bioprocessing, the continuous monitoring of glucose and lactate levels is crucial for optimizing cell culture conditions and thereby the research and development of biopharmaceutical products. Accurate measurement of these parameters allows for better control of the bioreactor environment, leading to improved productivity and reduced time to market.908 Devices’ MAVEN provides highly precise, on-line monitoring and control of glucose and lactate without any loss of bioreactor volume, enabling biopharma scientists to maintain optimal nutrient and metabolite concentrati
Show less
Read more
Impact Snapshot
Event Time:
MASS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MASS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MASS alerts
High impacting 908 Devices Inc. news events
Weekly update
A roundup of the hottest topics
MASS
News
- Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters [Yahoo! Finance]Yahoo! Finance
- Analysts Have Lowered Expectations For 908 Devices Inc. (NASDAQ:MASS) After Its Latest Results [Yahoo! Finance]Yahoo! Finance
- 908 Devices Inc. (NASDAQ: MASS) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.MarketBeat
- 908 Devices Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]Yahoo! Finance
- 908 Devices Inc. (NASDAQ: MASS) had its price target lowered by analysts at Stifel Nicolaus from $17.00 to $6.00. They now have a "buy" rating on the stock.MarketBeat
MASS
Earnings
- 11/12/24 - Miss
MASS
Sec Filings
- 12/19/24 - Form 4
- 12/16/24 - Form 4
- 11/14/24 - Form SC
- MASS's page on the SEC website